Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID‐19 pandemic: A population‐based, nation‐wide study
Open Access
- 19 March 2024
- journal article
- letter
- Published by Wiley in HemaSphere
- Vol. 8 (3) , e57
Abstract
No abstract availableFunding Information
- Alfred Benzon Foundation
This publication has 10 references indexed in Scilit:
- Survival trends in hematological malignancies in the Nordic countries through 50 yearsBlood Cancer Journal, 2022
- Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversionBlood, 2022
- Patients with CLL have a lower risk of death from COVID-19 in the Omicron eraBlood, 2022
- COVID-19 in patients with hematologic malignancyBlood, 2022
- Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disordersActa Oncologica, 2022
- Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer PatientsCancer Cell, 2021
- Rituximab maintenance improves overall survival of patients with follicular lymphoma—Individual patient data meta-analysisEuropean Journal of Cancer, 2017
- The Danish National Multiple Myeloma RegistryClinical Epidemiology, 2016
- The Danish National Chronic Lymphocytic Leukemia RegistryClinical Epidemiology, 2016
- The Danish National Lymphoma Registry: Coverage and Data QualityPLOS ONE, 2016